Evosep Biolabs ApS: Financial statements 2025
CVR: 44216701
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Evosep Biolabs ApS (CVR 44216701) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -3,615,000 and a net result of DKK -3,961,000. Equity in the 2025 report amounted to DKK 701,000. The solvency ratio was 100%.
- Gross Profit
- DKK -3,615,000
- Profit/Loss
- DKK -3,961,000
- Equity
- DKK 701,000
- Total Assets
- DKK 701,000
- Employees
- 0
Official annual report
How creditworthy is Evosep Biolabs ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 27, 2025, Jens Bornhøft Christensen is registered as director of Evosep Biolabs ApS.
As of November 27, 2025, Ole Vorm has stepped down as director of Evosep Biolabs ApS.
Evosep Biolabs ApS has published its interim report for the period July 28, 2023 – December 31, 2024.
About Evosep Biolabs ApS
Evosep Biolabs ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Bornhøft Christensen and Morten Bern. The company is owned by Evosep ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,615,000 and a net result of DKK -3,961,000. Equity in the 2025 report amounted to DKK 701,000.